The essential role of the in situ immune reaction in human colorectal cancer
- PMID: 18559950
- DOI: 10.1189/jlb.1107773
The essential role of the in situ immune reaction in human colorectal cancer
Abstract
Colorectal cancer is the second most common cause of cancer-related death. Novel prognostic factors should be identified and validated to refine the present tumor-node-metastasis system. The presence of immune cells infiltrating colorectal cancers is a common phenomenon. However, the current belief is that clinically detectable human tumors escaping immune surveillance are no longer kept in check by the immune cells of the tumor microenvironment. Despite studies showing the influence of immune cell infiltrates on the behavior of colorectal carcinomas, this parameter is not currently recognized as a reliable prognostic factor. We showed that the nature, functional orientation, density, and location of immune cells within distinct tumor regions could provide a prognostic factor superior to and independent of criteria related to the anatomic extent of the tumor. The strength of the immune reaction identified in our studies could advance our understanding of cancer evolution and have important consequences for clinical practice.
Similar articles
-
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.Science. 2006 Sep 29;313(5795):1960-4. doi: 10.1126/science.1129139. Science. 2006. PMID: 17008531
-
Coordination of intratumoral immune reaction and human colorectal cancer recurrence.Cancer Res. 2009 Mar 15;69(6):2685-93. doi: 10.1158/0008-5472.CAN-08-2654. Epub 2009 Mar 3. Cancer Res. 2009. PMID: 19258510
-
Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.J Clin Oncol. 2011 Feb 20;29(6):610-8. doi: 10.1200/JCO.2010.30.5425. Epub 2011 Jan 18. J Clin Oncol. 2011. PMID: 21245428
-
The adaptive immunologic microenvironment in colorectal cancer: a novel perspective.Cancer Res. 2007 Mar 1;67(5):1883-6. doi: 10.1158/0008-5472.CAN-06-4806. Cancer Res. 2007. PMID: 17332313 Review.
-
Immune infiltration in human tumors: a prognostic factor that should not be ignored.Oncogene. 2010 Feb 25;29(8):1093-102. doi: 10.1038/onc.2009.416. Epub 2009 Nov 30. Oncogene. 2010. PMID: 19946335 Review.
Cited by
-
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice.Cancer Immunol Res. 2017 Jun;5(6):468-479. doi: 10.1158/2326-6066.CIR-16-0284. Epub 2017 May 8. Cancer Immunol Res. 2017. PMID: 28483787 Free PMC article.
-
Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling.Oncotarget. 2017 Feb 28;8(9):15168-15181. doi: 10.18632/oncotarget.14834. Oncotarget. 2017. PMID: 28147310 Free PMC article.
-
Neoadjuvant calcium electroporation for potentially curable colorectal cancer.Surg Endosc. 2024 Feb;38(2):697-705. doi: 10.1007/s00464-023-10557-1. Epub 2023 Nov 28. Surg Endosc. 2024. PMID: 38017160
-
Increasing negative lymph node count predicts favorable OS and DSS in breast cancer with different lymph node-positive subgroups.PLoS One. 2018 Mar 19;13(3):e0193784. doi: 10.1371/journal.pone.0193784. eCollection 2018. PLoS One. 2018. PMID: 29554092 Free PMC article.
-
Lack of MHC class II molecules favors CD8+ T-cell infiltration into tumors associated with an increased control of tumor growth.Oncoimmunology. 2017 Dec 7;7(3):e1404213. doi: 10.1080/2162402X.2017.1404213. eCollection 2018. Oncoimmunology. 2017. PMID: 29399403 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical